비소세포폐암 환자의 종합 유전체 프로파일링 결과에 미치는 기존 단일 유전자 검사 영향

Nesline 외 (화요일)에 이 문제를 연구하였습니다.

www.synapsesocial.com/papers/68e734fcb6db6435876ae5aa — DOI: https://doi.org/10.1007/s40487-024-00270-x

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model· 2019 · 222 citations
2. Broad, Hybrid Capture–Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches· 2015 · 270 citations
3. Checkpoint Blockade in Lung Cancer With Driver Mutation: Choose the Road Wisely· 2020 · 106 citations
4. Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non–Small-Cell Lung Cancer· 2022 · 107 citations
5. Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology· 2020 · 29 citations